QTRX · Quanterix Corp · Webcasts, Transcripts & Audio
$3.78
+0.14 (+3.85%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$154.65M
Shares
47.29M
Volume · Oct 5
1.03M
Avg daily vol (3M)
751.21K
Quanterix Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Quanterix Corp (QTRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼3.8%
$26.65M
−$36.55M
'22 Q3
22-11-08
▼14.7%
$25.82M
−$18.20M
'22 Q4
23-03-06
▼3.7%
$28.46M
−$7.27M
'23 Q1
23-05-09
▲31.1%
$30.80M
−$5.55M
'23 Q2
23-08-07
▲18.4%
$31.56M
−$6.72M
'23 Q3
23-11-06
▲22.2%
$31.55M
−$8.81M
'23 Q4
24-02-29
▲12.7%
$32.07M
−$11.16M
'24 Q1
24-05-07
▲11.6%
$34.38M
−$7.39M
'24 Q2
24-08-08
▲13.5%
$35.81M
−$8.35M
'24 Q3
24-11-12
▼5.4%
$30.33M
−$20.50M
'25 Q1
25-05-12
▲11.4%
$35.16M
−$11.63M
'24 Q4
25-05-12
▼28.8%
$24.48M
−$30.01M
'25 Q2
25-08-07
▲12.3%
$40.23M
−$33.52M
'25 Q3
25-11-10
▲24.7%
$43.85M
−$23.12M
'25 Q4
26-03-02
▲20.1%
$36.41M
−$17.54M
'26 Q1
26-05-06
LATEST
▲34.4%
$32.91M
−$48.93M
'26 Q2
26-08-10
Conference
Investor event
2026-08-12
Quanterix Corp (QTRX) August 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-10
Quanterix Corp (QTRX) Q2 2026 Earnings Call Transcript
Cautious tone
Spatial and Simoa instruments/research tools
Diagnostics growth and Lucent AD
CMS pricing and FDA pathway
Revenue
$32.91M
▲ 34.4% YoY Diluted EPS
$-1.04
Gross margin
38.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Quanterix Corp (QTRX) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Quanterix Corp (QTRX) Q1 2026 Earnings Call Transcript
Positive tone
Product launches and platform upgrades
Alzheimer's diagnostics growth investment
Commercial execution and sales force buildout
Revenue
$36.41M
▲ 20.1% YoY Diluted EPS
$-0.37
Gross margin
42.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-02
Quanterix Corp (QTRX) Q4 2025 Earnings Call Transcript
Confident tone
Simoa and Spatial product lines
Alzheimer's diagnostics opportunity
Accelerator lab and pharma demand
Revenue
$43.85M*
▲ 24.7% YoY Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Quanterix Corp (QTRX) Q3 2025 Earnings Call Transcript
Positive tone
Revenue and end-market conditions
Accelerator lab services
Instrument placements and recovery
Revenue
$40.23M
▲ 12.3% YoY Diluted EPS
$-0.73
Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Quanterix Corp (QTRX) Q2 2025 Earnings Call Transcript
Positive tone
Akoya Acquisition & Integration
Cost Synergies & Path to Cash Flow Positive
Proteomics & Long-Term Market Opportunity
Revenue
$24.48M
▼ 28.8% YoY Diluted EPS
$-0.77
Gross margin
40.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-05-12
Quanterix Corp (QTRX) Q4 2024 Earnings Call Transcript
Positive tone
Revenue growth and recurring revenue
Simoa ONE platform and menu expansion
Akoya Biosciences acquisition and synergies
Revenue
$35.16M*
▲ 11.4% YoY Gross margin
63.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q1
2025-05-12
Quanterix Corp (QTRX) Q1 2025 Earnings Call Transcript
Balanced tone
Revenue and Guidance
Simoa ONE Platform
Accelerator / Pharma
Revenue
$30.33M
▼ 5.4% YoY Diluted EPS
$-0.53
Gross margin
48.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-12
Quanterix Corp (QTRX) Q3 2024 Earnings Call Transcript
Positive tone
Alzheimer's Disease Diagnostics
Neurology and Biomarker Menu Expansion
Restatement and Preliminary Results Risk
Revenue
$35.81M
▲ 13.5% YoY Diluted EPS
$-0.22
Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Quanterix Corp (QTRX) Q2 2024 Earnings Call
Revenue
$34.38M
▲ 11.6% YoY Diluted EPS
$-0.19
Gross margin
64.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Quanterix Corp (QTRX) Q1 2024 Earnings Call Transcript
Confident tone
Quarterly revenue and consumables growth
Alzheimer's disease diagnostics and tau biomarkers
BioHermes and CANTATA clinical trials / multi-marker test
Revenue
$32.07M
▲ 12.7% YoY Diluted EPS
$-0.29
Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Quanterix Corp (QTRX) Q4 2023 Earnings Call Transcript
Confident tone
Alzheimer's diagnostics and p-Tau 217
Simoa technology platform innovation
2024 financial guidance and diagnostics spending
Revenue
$31.55M
▲ 22.2% YoY Diluted EPS
$-0.23
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Quanterix Corp (QTRX) Q3 2023 Earnings Call Transcript
Revenue
$31.56M
▲ 18.4% YoY Diluted EPS
$-0.18
Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Quanterix Corp (QTRX) Q2 2023 Earnings Call Transcript
Revenue
$30.80M
▲ 31.1% YoY Diluted EPS
$-0.15
Gross margin
63.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Quanterix Corp (QTRX) Q1 2023 Earnings Call Transcript
Revenue
$28.46M
▼ 3.7% YoY Diluted EPS
$-0.19
Gross margin
56.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-06
Quanterix Corp (QTRX) Q4 2022 Earnings Call Transcript
Revenue
$25.82M
▼ 14.7% YoY Diluted EPS
$-0.49
Gross margin
49.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Quanterix Corp (QTRX) Q3 2022 Earnings Call Transcript
Revenue
$26.65M
▼ 3.8% YoY Diluted EPS
$-0.99
Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Quanterix Corp (QTRX) Q2 2022 Earnings Call Transcript
Revenue
$23.50M
▼ 7.4% YoY Diluted EPS
$-0.73
Gross margin
35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Quanterix Corp (QTRX) Q1 2022 Earnings Call Transcript
Revenue
$29.55M
▲ 8.6% YoY Diluted EPS
$-0.49
Gross margin
47.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Quanterix Corp (QTRX) Q4 2021 Earnings Call Transcript
Revenue
$30.29M*
▲ 15.9% YoY Gross margin
63.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Quanterix Corp (QTRX) Q3 2021 Earnings Call Transcript
Revenue
$27.69M
▼ 11.8% YoY Diluted EPS
$-0.43
▼ 714.3% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Quanterix Corp (QTRX) Q2 2021 Earnings Call Transcript
Revenue
$25.37M
▲ 93.2% YoY Diluted EPS
$-0.33
Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-05
Quanterix Corp (QTRX) Q1 2021 Earnings Call Transcript
Revenue
$27.21M
▲ 73% YoY Diluted EPS
$-0.29
Gross margin
60.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Quanterix Corp (QTRX) Q4 2020 Earnings Call Transcript
Revenue
$26.13M
▲ 64.2% YoY Diluted EPS
$-0.31
Gross margin
57.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Quanterix Corp (QTRX) Q3 2020 Earnings Call Transcript
Revenue
$31.39M
▲ 110% YoY Diluted EPS
$0.07
Gross margin
67.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Quanterix Corp (QTRX) Q2 2020 Earnings Call Transcript
Revenue
$13.13M
▼ 3% YoY Diluted EPS
$-0.43
Gross margin
39.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Quanterix Corp (QTRX) Q1 2020 Earnings Call Transcript
Revenue
$15.73M
▲ 27.5% YoY Diluted EPS
$-0.41
Gross margin
43.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-09
Quanterix Corp (QTRX) Q4 2019 Earnings Call
Revenue
$15.92M
▲ 46.3% YoY Gross margin
43.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–29 of 29 webcasts